Necessary to Identify Latent Toxicants A
Abstract
Keywords
Full Text:
PDFReferences
Chary MA, Barbuto AF, Izadmehr S, Hayes BD, Burns MM.
COVID‑19: Therapeutics and their toxicities. J Med Toxicol
;16:284‑94.
Kara E, Inkaya AC, Demirkan K. May drug‑related
cardiovascular toxicities persist after hospital discharge in
COVID‑19 patients? Int J Antimicrob Agents 2020;55:106003.
Neumann NR, Chai PR, Wood DM, Greller HA, Mycyk MB.
Medical toxicology and COVID‑19: Our role in a pandemic.
J Med Toxicol 2020;16:245‑7.
Aminpour M, Delgado WE, Wacker S, Noskov S, Houghton M,
Tyrrell DL, et al. Computational determination of toxicity risks
associated with a selection of approved drugs having demonstrated
activity against COVID‑19. BMC Pharmacol Toxicol 2021;22:61.